Bioorthogonal Equipping CAR-T Cells with Hyaluronidase and Checkpoint Blocking Antibody for Enhanced Solid Tumor Immunotherapy

[Image: see text] Adoptive cellular therapy utilizing chimeric antigen receptor redirected T (CAR-T) cells has shown impressive therapeutic effects on hematological malignancies. In contrast, the efficacy of CAR-T therapies in treating solid tumors is still poor, which is largely due to inefficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yangyang, Dong, Yansong, Yang, Shuhan, Tu, Yalan, Wang, Chengbo, Li, Jun, Yuan, Youyong, Lian, Zhexiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136969/
https://www.ncbi.nlm.nih.gov/pubmed/35647274
http://dx.doi.org/10.1021/acscentsci.2c00163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136969/
https://www.ncbi.nlm.nih.gov/pubmed/35647274
http://dx.doi.org/10.1021/acscentsci.2c00163

Ejemplares similares